A randomized controlled trial to assess pharmacist-physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan

Journal of Managed Care Pharmacy

Volumn 17, Issue 4, 2011, Pages 295-303

  Hammad, Eman A ^a   Yasein, Nada ^a   Tahaineh, Linda ^a   Albsoul Younes, Abla M ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HUMAN RELATION; JORDAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHARMACIST; PHYSICIAN; SYSTOLIC BLOOD PRESSURE; UNIVERSITY; WAIST CIRCUMFERENCE;

EID: 79960689509     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2011.17.4.295     Document Type: Article

References (28)

1. Grundy SM, Brewer HB Jr., Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13-e18. Available at: http://atvb.ahajournals.org/cgi/reprint/24/2/e13. Accessed April 8, 2011.
2. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH Publication No. 02-5215. September 2002. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed April 8, 2011.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. Available at: http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf. Accessed April 8, 2011.
4. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442-43.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Health Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52. Available at: http://circ.ahajournals.org/cgi/reprint/112/17/2735. Accessed April 8, 2011.
6. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6):295-300. Available at: http://www.jstage.jst.go.jp/article/jat/12/6/295/_pdf. Accessed April 8, 2011.
7. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009;(13):1-7. Available at: http://www.cdc.gov/nchs/data/nhsr/nhsr013.pdf. Accessed April 8, 2011.
8. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among northern Jordanians. J Diabetes Complications. 2007;21(4):214-19.
9. Sorkhou El, Al-Qallaf B, Al-Namash HA, Ben-Nakhi A, Al-Batish MM, Habiba SA. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med Princ Pract. 2004;13(1):39-42. Available at: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&Art ikelNr=74050&Ausgabe=229696&ProduktNr=224259&filename=74050. pdf. Accessed April 8, 2011.
10. Haddad FH, Mahafza SM. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome. Saudi Med J. 2008;29(9):1299-305. Available at: http://www.smj.org.sa/PDFFiles/Sep08/14Impact20080570.pdf. Accessed April 8, 2011.
11. Al-Nozha M, Al-Khadra A, Arafah MR, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J. 2005;26(12):1918-25.
12. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urbanrural comparison. Diabetes Care. 2001;24(2):275-79. Available at: http://care.diabetesjournals.org/content/24/2/275.full.pdf. Accessed March 25, 2011.
13. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia. 2005;48(4):649-56. Available at: http://www.springerlink.com/content/p572106068562l7j/fulltext.pdf. Accessed April 8, 2011.
14. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-89. Available at: http://care.diabetesjournals.org/content/24/4/683.full.pdf. Accessed April 8, 2011.
15. Vega GL. Results of expert meetings: obesity and cardiovascular disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J. 2001;142(6):1108-16.
16. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; for DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164(1):1066-76. Available at: http://archinte.ama-assn.org/cgi/reprint/164/10/1066. Accessed April 8, 2011.
17. Ramser KL, Sprabery LR, George CM, et al. Physician-pharmacist collaboration in the management of patients with diabetes resistant to usual care. Diabetes Spectrum. 2008;21(3):209-14. Available at: http://spectrum.diabetesjournals.org/content/21/3/209.full.pdf. Accessed April 8, 2011.
18. Cording MA, Engelbrecht-Zadvorny EB, Pettit BJ, Eastham JH, Sandoval R. Development of a pharmacist-managed lipid clinic. Ann Pharmacother. 2002;36(5):892-904.
19. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002. Available at: http://archinte.ama-assn.org/cgi/reprint/169/21/1996. Accessed April 8, 2011.
20. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757-63. Available at: http://archinte.amaassn.org/cgi/reprint/169/8/757.pdf. Accessed April 8, 2011.
21. Kelly CJG, Booth G. Pharmacist-led structured care for patients with diabetic nephropathy. Br J Diabetes Vasc Dis. 2008;8(2):86-88. Available at: http://dvd.sagepub.com/content/8/2/86.full.pdf. Accessed April 8, 2011.
22. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168(21):2355-61. Available at: http://archinte.ama-assn.org/cgi/reprint/168/21/2355.pdf. Accessed April 8, 2011.
23. Olenak JL, Calpin M. Establishing a cardiovascular health and wellness program in a community pharmacy: screening for metabolic syndrome. J Am Pharm Assoc (2003). 2010;50(1):32-36.
24. Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009;29(8):975-87.
25. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. Your guide to lowering your blood pressure with DASH. NIH Publication No. 06-4082. Originally Printed 1998. Revised April 2006. Available at: http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf. Accessed April 8, 2011.
26. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute, in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. NIH Publication 98-4083. September 1998. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed April 8, 2011.
27. Cromwell J, McCall N, Burton J. Evaluation of Medicare Health Support Chronic Disease Pilot Program. Health Care Financ Rev. 2008;30(1):47-60. Available at: http://www4.cms.gov/HealthCareFinancingReview/downloads/08Fallpg47.pdf. Accessed April 8, 2011.
28. Klepser DG, Huether JR, Handke LJ, Williams CE. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance. J Manag Care Pharm. 2007;13(9):765-77. Available at: http://www.amcp.org/data/jmcp/JMCPMaga_N-D%2007_765-777.pdf.